The Effect of Cisplatin Toxicity and Capsaicin on Electron Transport Chain in Liver and Kidney of Sprague Dawley Rats

Cell Biochemistry and Biophysics

Volumn 69, Issue 3, 2014, Pages 707-716

  Kursunluoglu, Gizem ^a   Kayali, Hulya Ayar ^a   Taskiran, Dilek ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

ADP; ATP; Capsaicin; CAT; Cisplatin; ETC; LPO

Indexed keywords

RATTUS;

ANTIOXIDANT; CAPSAICIN; CISPLATIN;

ANIMAL; CELL PROTECTION; DRUG EFFECTS; ENZYMOLOGY; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; CAPSAICIN; CISPLATIN; CYTOPROTECTION; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84902375269     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9857-z     Document Type: Article

References (46)

1. Cvitkovic, E. (1998). Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treatment Reviews, 24, 265-281.
2. Hanigan, M. H., & Devarajan, P. (2003). Cisplatin nephrotoxicity: Molecular mechanisms. Cancer Therapy, 1, 47-61.
3. Mollman, J. E., Glover, D. J., Hogan, W. M., & Furman, R. E. (1988). Cisplatin neuropathy risk factors, prognosis and protection by WR-2721. Cancer, 61, 2192-2195.
4. Screnci, D., & McKeage, M. J. (1999). Platinum neurotoxicity: Clinical profiles, experimental models and neuroprotective approaches. Journal of Inorganic Biochemistry, 77, 105-110.
5. Brady, H. R., Kone, B. C., Stromski, M. E., Zeidel, M. L., Giebisch, G., & Gullans, S. R. (1990). Mitochondrial injury: An early event in cisplatin toxicity to renal proximal tubules. American Journal of Physiology, 258, 1181-1187.
6. Huang, H., Zhu, L., Reid, B. R., Drobny, G. P., & Hopkins, P. B. (1995). Solution structure of a cisplatin-induced DNA interstrand cross-link. Science, 270, 1842-1845.
7. Jiang, S., Song, M. J., Shin, E. C., Lee, M. O., Kim, S. J., & Park, J. H. (1999). Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways. Hepatology, 29, 101-110.
8. Wallance, D. C. (1999). Mitochondrial diseases in man and mouse. Science, 283, 1482-1488.
9. Loschen, G., Flohe, L., & Chance, B. (1971). Respiratory chain linked production in pigeon heart mitochondria. FEBS Letters, 18, 261-264.
10. Boveris, A., & Cadenas, E. (1975). Mitochondrial production of super-oxide anions and its relationship to antimycin insensitive respiration. FEBS Letters, 54, 311-314.
11. Sangeetha, P., Das, U. N., Koratkar, R., & Suryaprabha, P. (1990). Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radical Biology & Medicine, 8, 15-19.
12. Look, M. P., & Musch, E. (1994). Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy, 40, 8-15.
13. Weijl, N. I., Cleton, F. J., & Osanto, S. (1997). Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Reviews, 23, 209-240.
14. Antunes, L. M. G., Darin, J. D. C., & Bianchi, M. L. P. (2000). Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependant study. Pharmacological Research, 41, 405-411.
15. Antunes, L. M. G., Darin, J. D. C., & Bianchi, M. L. P. (2001). Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacological Research, 43, 145-150.
16. Caffrey, P. B., & Frenkel, G. D. (2000). Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo. Cancer Chemotherapy Pharmacology, 46, 74-78.
17. Gamal el-Din, A. M., & Al-Bekairi, A. M. (2006). Carvedilol, a beta adrenoceptor blocker with antioxidative potential, attenuates cisplatin-induced nephrotoxicity in rats. Journal of Applied Sciences Research, 2, 331-335.
18. Koyner, J. L., Sher Ali, R., & Murray, P. T. (2008). Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron Experimental Nephrology, 109, 109-117.
19. Links, M., & Lewis, C. (1999). Chemoprotectants: A review of their clinical pharmacology and therapeutic efficacy. Drugs, 57, 293-308.
20. Hatefi, Y., & Galante, Y. M. (1981). Isolation of cytochrome from complex II (succinate ubiquinone oxidoreductase) and its reconstitution with succinate dehydrogenase. Journal of Biological Chemistry, 255, 5530-5537.
21. Wharton, D. C., & Tzagoloff, A. (1967). Cytochrome oxidase from beef heart mitochondria. Methods in Enzymology, 10, 245-250.
22. Aebi, H. (1974). Catalase. In H. U. Bergmeyer (Ed.), Methods of enzymatic analysis (pp. 673-685). New York: Academic Press.
23. Buege, J. A., & Aust, S. D. (1978). Microsomal lipid peroxidation. In S. P. Colowick & N. O. Kaplan (Eds.), Methods in enzymology (pp. 302-316). New York: Academic Press.
24. Cardoso, S. M., Pereira, C., & Oliveira, R. (1999). Mitochondrial function is differentially affected upon oxidative stress. Free Radical Biology & Medicine, 26, 3-13.
25. Masubuchi, Y., Suda, C., & Horie, T. (2005). Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. Journal of Hepatology, 42, 110-116.
26. Ganzera, M., Vrabl, P., Wörle, E., Burgstaller, W., & Stuppner, H. (2006). Determination of adenine and pyridine nucleotides in glucose-limited chemostat cultures of Penicillium simplicissimum by one-step ethanol extraction and ion-pairing liquid chromatography. Analytical Biochemistry, 359, 132-140.
27. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
28. Schwenk, M. (1987). Drug transport in intestine, liver and kidney. Archives of Toxicology, 60, 37-42.
29. Valentovic, M. A., Scott, L. A., Madan, E., & Yokel, R. A. (1991). Renal accumulation and urinary excretion of cisplatin in diabetic rats. Toxicology, 70, 151-162.
30. Kruidering, M., De Water, B. V., De Heer, E., Mulder, G. J. J., & Nagelkerke, F. (1996). Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: Mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. Journal of Pharmacology and Experimental Therapeutics, 280, 638-649.
31. Martins, N. M., Santos, N. A. G., Curti, C., Bianchil, M. L. P., & Santos, A. C. (2008). Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. Journal of Applied Toxicology, 28, 337-344.
32. Pratibha, R., Sameer, R., Rataboli, P. V., Bhiwgade, D. A., & Dhume, C. Y. (2006). Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats. European Journal of Pharmacology, 532, 290-293.
33. Sadzuka, Y., Shoji, T., & Takino, Y. (1992). Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochemical Pharmacology, 43, 1872-1875.
34. Zicca, A., Cafaggi, S., Mariggio, M. A., Vannozzi, M. O., Ottone, M., Bocchini, V., et al. (2002). Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. European Journal of Pharmacology, 442, 265-272.
35. Cersosimo, R. J. (1993). Hepatotoxicity associated with cisplatin chemotherapy. Annals of Pharmacotherapy, 27, 438-441.
36. Prasad, S. B., Rosangkima, G., & Kharbangar, A. (2010). Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice. Mitochondrion, 10, 38-45.
37. Singh, G. A. (1989). Possible cellular mechanism of cisplatin-induced nephrotoxicity. Toxicology, 58, 71-80.
38. Gerschenson, M., Paik, C. Y., Gaukler, E. L., Diwan, B. A., & Poirier, M. C. (2001). Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses. Reproductive Toxicology, 15, 525-531.
39. Daley-Yates, P. T., & McBrien, D. C. H. (1982). The inhibition of renal ATPase by cisplatin and some bio-transformation products. Chemico-Biological Interactions, 40, 325-334.
40. + transport, and cisplatin-induced apoptosis in renal cells. Journal of Biological Chemistry, 277, 43377-43388.
41. Aleisa, A. M., Al-Majed, A. A., Al-Yahya, A. A., Al-Rejaie, S. S., Bakheet, S. A., Al-Shabanah, O. A., et al. (2007). Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-l-carnitine in rat kidney tissues. Clinical and Experimental Pharmacology and Physiology, 34, 1252-1259.
42. Lehninger, A. L. (1964). The mitochondrion. New York: Benjamin.
43. Kogure, K., Goto, S., Nishimura, M., Yasumoto, M., Abe, K., Ohiwa, C., et al. (2002). Mechanism of potent antiperoxidative effect of capsaicin. Biochimica et Biophysica Acta, 1573, 84-92.
44. Henderson, D. E., & Henderson, S. K. (1992). Thermal decomposition of capsaicin. 1. Interactions with oleic acid at high temperatures. Journal of Agricultural and Food Chemistry, 40, 2263-2268.
45. Kogure, K., Goto, S., Abe, K., Ohiwa, C., Akasu, M., & Terada, H. (1999). Potent antiperoxidation activity of the bisbenzylisoquinoline alkaloid cepharanthine: the amine moiety is responsible for its pH-dependent radical scavenge activity. Biochimica et Biophysica Acta, 1426, 133-142.
46. Goto, S., Kogure, K., Abe, K., Kimata, Y., Kitahama, K., Yamashita, E., et al. (2001). Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochimica et Biophysica Acta, 1512, 251-258.